Vote Scores
Filings read through

Dyne Therapeutics, Inc.: how funds voted at the meeting of 30 May 2025

Ticker
DYN
Meeting
Season
year to 30 June 2025
Filers reporting
295
Ballot items
4

295 filers on Form N-PX reported votes at the Dyne Therapeutics, Inc. meeting of 30 May 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Dyne Therapeutics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 54.3% of the reported votes are for. 56 filers withheld from or voted against at least one nominee.

    400 vote records from 108 filers. 43 of the 108 filers that marked the item voted against management.

    • Positions of 33 fund families
    • For 16
    • Abstain or withhold 15
    • Split or no vote 2
    • Against management 15
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    436 vote records from 294 filers. 107 of the 279 filers that marked the item voted against management. 15 filers gave no management mark.

    • Positions of 37 fund families
    • For 20
    • Against 17
    • Against management 17
  3. Item 3: Frequency of the say-on-pay vote

    One year: 262 filers. For: 6 filers. Three years: 4 filers. Abstain: 2 filers. Takenoaction: 1 filer. 1yr: 1 filer.

    434 vote records from 291 filers. 5 of the 276 filers that marked the item voted against management. 15 filers gave no management mark.

    • Positions of 37 fund families
    • Split or no vote 37
    • Against management 1
  4. Item 4: Audit-related items (auditor ratification)

    200 vote records from 108 filers. 1 of the 108 filers that marked the item voted against management.

    • Positions of 33 fund families
    • For 33

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Dyne Therapeutics, Inc., meeting of 30 May 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinForSplitNo report
BlackRock and iSharesAgainst, against managementSplitFor
BNY MellonForSplitFor
Brighthouse FundsForSplitFor
Charles SchwabAgainst, against managementSplitFor
Columbia ThreadneedleAgainst, against managementSplitFor
DimensionalAgainst, against managementSplit, against managementNo report
DWSForSplitFor
EquitableAgainst, against managementSplitFor
FidelityForSplitFor
Franklin TempletonAgainst, against managementSplitFor
Global XAgainst, against managementSplitFor
Goldman SachsAgainst, against managementSplitFor
Guggenheim and RydexForSplitFor
InvescoAgainst, against managementSplitFor
J.P. MorganForSplitFor
Janus HendersonForSplitFor
John Hancock and ManulifeForSplitFor
Lincoln FinancialAgainst, against managementSplitFor
MassMutualForSplitFor
Morgan Stanley, Eaton Vance and CalvertForSplitFor
NationwideAgainst, against managementSplitFor
Neuberger BermanAgainst, against managementSplitNo report
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsAgainst, against managementSplitFor
PGIM and PrudentialAgainst, against managementSplitNo report
PrincipalForSplitFor
ProShares and ProFundsForSplitFor
Russell InvestmentsAgainst, against managementSplitFor
SEIAgainst, against managementSplitFor
State Street and SPDRAgainst, against managementSplitFor
T. Rowe PriceForSplitFor
TransamericaForSplitFor
VanguardForSplitFor
Victory CapitalForSplitFor
VoyaForSplitFor

Questions

How many filers reported votes at the Dyne Therapeutics, Inc. meeting?
295 Form N-PX filers reported votes at the meeting of 30 May 2025. On say-on-pay, 107 of 279 filers that marked the item voted against management (38.4%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Dyne Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Dyne Therapeutics, Inc. with a meeting date within three days of 30 May 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .